Literature DB >> 17227308

Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia?

P Chandrasoma1, K Wickramasinghe, Y Ma, T DeMeester.   

Abstract

Adenocarcinoma of the distal esophagus and gastroesophageal junction are believed to arise in Barrett's esophagus with intestinal metaplasia. Whether adenocarcinoma can arise in columnar lined esophagus without intestinal metaplasia is in doubt. Whether adenocarcinoma of the gastric cardia arises in intestinal metaplasia of the gastric cardia is also in doubt. We aim to evaluate the relationship of size and stage of adenocarcinoma of the distal esophagus, gastroesophageal junction and gastric cardia to intestinal metaplasia and other types of columnar epithelium. Seventy-four patients who had esophagogastrectomy for adenocarcinomas in this region were examined histologically to assess the frequency of residual intestinal metaplasia in the surrounding epithelium. Tumors without residual intestinal metaplasia were evaluated for the presence of other columnar epithelia and correlated with tumor size and stage. Cardiac mucosa was present around all tumors. Residual intestinal metaplasia was present in 48 (65%) tumors, including 33/38 (87%) distal esophageal, 10/25 (45%) junctional and 5/11 (45%) gastric cardia tumors. The prevalence of intestinal metaplasia was 100% in all tumors that were less than 1 cm in maximum diameter and all intramucosal tumors. The prevalence of residual intestinal metaplasia decreased with increasing tumor size and stage. These data strongly support the contention that adenocarcinomas of this region, including those in the gastric cardia, arise in intestinal metaplastic epithelium. The absence of residual intestinal metaplasia in larger tumors is the result of tumor overgrowing the intestinal metaplasia from which it arose.

Entities:  

Mesh:

Year:  2007        PMID: 17227308     DOI: 10.1111/j.1442-2050.2007.00638.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  21 in total

1.  Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.

Authors:  Shivaram Bhat; Helen G Coleman; Fouad Yousef; Brian T Johnston; Damian T McManus; Anna T Gavin; Liam J Murray
Journal:  J Natl Cancer Inst       Date:  2011-06-16       Impact factor: 13.506

2.  Carcinogenesis of Barrett's esophagus: a review of the clinical literature.

Authors:  Jiro Watari; Tadayuki Oshima; Hirokazu Fukui; Toshihiko Tomita; Hiroto Miwa
Journal:  Clin J Gastroenterol       Date:  2013-08-14

Review 3.  Molecular mechanisms of Barrett's esophagus.

Authors:  Hao Chen; Yu Fang; Whitney Tevebaugh; Roy C Orlando; Nicholas J Shaheen; Xiaoxin Chen
Journal:  Dig Dis Sci       Date:  2011-10-08       Impact factor: 3.199

4.  Comparison of cancer-associated genetic abnormalities in columnar-lined esophagus tissues with and without goblet cells.

Authors:  Santhoshi Bandla; Jeffrey H Peters; David Ruff; Shiaw-Min Chen; Chieh-Yuan Li; Kunchang Song; Kimberly Thoms; Virginia R Litle; Thomas Watson; Nikita Chapurin; Michal Lada; Arjun Pennathur; James D Luketich; Derick Peterson; Austin Dulak; Lin Lin; Adam Bass; David G Beer; Tony E Godfrey; Zhongren Zhou
Journal:  Ann Surg       Date:  2014-07       Impact factor: 12.969

Review 5.  Diagnosis and Surveillance of Barrett's Esophagus: Addressing the Transatlantic Divide.

Authors:  Saad Ghaus; Helmut Neumann; Humayun Muhammad; Gian Eugenio Tontini; Sauid Ishaq
Journal:  Dig Dis Sci       Date:  2016-04-01       Impact factor: 3.199

6.  Systemic activation of K-ras rapidly induces gastric hyperplasia and metaplasia in mice.

Authors:  Smita S Matkar; Amy Durham; Angela Brice; Timothy C Wang; Anil K Rustgi; Xianxin Hua
Journal:  Am J Cancer Res       Date:  2011-04-01       Impact factor: 6.166

7.  The risk of Barrett's esophagus associated with abdominal obesity in males and females.

Authors:  Bradley J Kendall; Graeme A Macdonald; Nicholas K Hayward; Johannes B Prins; Suzanne O'Brien; David C Whiteman
Journal:  Int J Cancer       Date:  2012-10-30       Impact factor: 7.396

8.  The columnar-lined mucosa at the gastroesophageal junction in non-human primates.

Authors:  Carlos A Rubio; Edward J Dick; Natalia E Schlabritz-Loutsevitch; Abiel Orrego; Gene B Hubbard
Journal:  Int J Clin Exp Pathol       Date:  2008-01-20

9.  The potential impact of contemporary developments in the management of patients with gastroesophageal reflux disease undergoing an initial gastroscopy.

Authors:  Suhail B Salem; Yael Kushner; Victoria Marcus; Serge Mayrand; Carlos A Fallone; Alan N Barkun
Journal:  Can J Gastroenterol       Date:  2009-02       Impact factor: 3.522

10.  Total body fat and the risk of Barrett's oesophagus - a bioelectrical impedance study.

Authors:  Bradley J Kendall; Graeme A Macdonald; Johannes B Prins; Suzanne O'Brien; David C Whiteman
Journal:  Cancer Epidemiol       Date:  2014-04-13       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.